JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 18 No. 9 937-939
© 1977 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hegge, F. N.
Right arrow Articles by Larson, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hegge, F. N.
Right arrow Articles by Larson, S. M.

The Incorporation of Ga-67 into the Ferritin Fraction of Rabbit Hepatocytes In Vivo

Frederick N. Hegge, Delmar J. Mahler and Steven M. Larson

Veterans Administration Hospital, Portland, Oregon

Correspondence: For reprints contact: Steven M. Larson, Nuclear Medicine Section (115), Veterans Administration Hospital, 4435 Beacon Avenue S., Seattle, WA 98108.

ABSTRACT

Twenty-four hours after the administration of Ga-67 citrate and Fe-59 citrate, rabbits were killed and their livers removed and homogenized. Labile proteins in the filtered liver homogenates were denatured; ferritin was then crystallized from the supernatants by cadmium sulfate. Sephadex G-200 gel filtration of the ferritin fractions was done to determine the distribution of molecular weights in the substances associated with Ga-67 and Fe-59. It was found that Ga-67 was incorporated into the crystallizable ferritin fraction of rabbit hepatocytes with approximately one-sixth the uptake of simultaneously administered Fe-59. Gel-filtration chromatography confirmed that both the Ga-67 and the Fe-59 of the crystallizable ferritin fraction were associated with substances of the appropriate molecular weight for ferritin.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
N. P. Davies, Y. S. Rahmanto, C. R. Chitambar, and D. R. Richardson
Resistance to the Antineoplastic Agent Gallium Nitrate Results in Marked Alterations in Intracellular Iron and Gallium Trafficking: Identification of Novel Intermediates
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 153 - 162.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. R. Chitambar and J. P. Wereley
Resistance to the Antitumor Agent Gallium Nitrate in Human Leukemic Cells Is Associated with Decreased Gallium/Iron Uptake, Increased Activity of Iron Regulatory Protein-1, and Decreased Ferritin Production
J. Biol. Chem., May 2, 1997; 272(18): 12151 - 12157.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1977 by the Society of Nuclear Medicine.